Foley Hoag Represents Biogen in $1 Billion Credit Facility

February 5, 2020

Foley Hoag LLP advised Biogen Inc. (Nasdaq: BIIB), a global biotechnology company, in connection with its $1.0 billion senior unsecured revolving credit facility.

Biogen entered the credit deal with Bank of America NA — as administrative agent, swing line lender and the L/C issuer — as well as other lenders.

Based in Cambridge, MA, Biogen discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide.

Foley Hoag lawyers Thomas Draper, Anne Seymour and Matthew Burton represented Biogen in the transaction.

About Foley Hoag LLP

Foley Hoag provides innovative, strategic legal services to public, private and government clients across the globe. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and private funds fields, and in cross-border disputes. The diverse backgrounds, perspectives and experiences of our lawyers and staff contribute to the exceptional senior level service we deliver to clients ranging from startups to multinational companies to sovereign states. For more information, visit www.foleyhoag.com or follow @FoleyHoag on Twitter.